Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07520643

MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling

Multilevel and Interdisciplinary Assessment of Subclinical to Clinical Atherosclerosis Interactions With Neurocognitive Function and Cardiovascular System Through Endothelial and Inflammatory Cell Signalling: The MISTIC Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The MISTIC study is a non-profit, cross-sectional clinical research project aimed at investigating the relationship between atherosclerosis and both cardiovascular and cognitive function in adult populations. Atherosclerosis is a progressive condition characterized by the accumulation of material within arterial walls, leading to vascular narrowing and impaired blood flow. While its most recognized consequences are acute events such as myocardial infarction or stroke, earlier stages of the disease, often asymptomatic, may already be associated with functional changes affecting multiple organ systems. This study focuses on evaluating the association between vascular health and cognitive performance at a single time point. Atherosclerotic burden will be assessed using non-invasive imaging techniques, including carotid intima-media thickness and coronary calcium scoring. Cognitive performance will be measured using standardized neuropsychological tests. Approximately 1000 participants will be enrolled and divided into two groups: a control group without clinically established cardiovascular disease, and a group of patients with coronary artery disease (CAD). All participants will undergo clinical evaluation, vascular imaging, cognitive testing, and analysis of biological samples. The primary objective is to determine whether increasing atherosclerotic burden is associated with measurable differences in cognitive and cardiovascular function. Secondary aims include identifying patterns that may help improve early detection and risk stratification of vascular disease. The results of this study are expected to contribute to a better understanding of atherosclerosis as a systemic condition and to support the development of preventive strategies targeting early stages of vascular disease.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPeripheral Vascular ImagingPeripheral Vascular Imaging of Carotid and Femoral Arteries by Eco-Doppler Ultrasound
DIAGNOSTIC_TESTCoro-CTCoronary Computed Axial Tomography (Coro-TC) with contrast administration
DIAGNOSTIC_TESTNeurocognitive AssesmentStudy of neurocognitive function and decline by pre-established tests
PROCEDUREBlood SamplingBlood sampling for further molecular and cellular analysis

Timeline

Start date
2026-05-01
Primary completion
2030-04-30
Completion
2030-04-30
First posted
2026-04-09
Last updated
2026-04-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07520643. Inclusion in this directory is not an endorsement.